(Total Views: 563)
Posted On: 03/17/2021 6:05:44 PM
Post# of 153903
CDiddy -
Much, much thanks.
How many other board leaders tried, but failed, to gently guide an active, constructive, scientific conversation over how long - 6 months?
I'll still be around because I'm still invested and because I think the data says leronlimab can save lives.
We had a "what could go wrong" discussion long ago. My response was that the 2:1 split meant our tiny control group was subject to huge random sampling swings in underlying health. Yep.
I didn't foresee the low number of criticals or the 75 patients getting no other treatment (who were they?). I think the board discounted these as well.
But all issues were well discussed.
Much, much thanks.
How many other board leaders tried, but failed, to gently guide an active, constructive, scientific conversation over how long - 6 months?
I'll still be around because I'm still invested and because I think the data says leronlimab can save lives.
We had a "what could go wrong" discussion long ago. My response was that the 2:1 split meant our tiny control group was subject to huge random sampling swings in underlying health. Yep.
I didn't foresee the low number of criticals or the 75 patients getting no other treatment (who were they?). I think the board discounted these as well.
But all issues were well discussed.
(5)
(0)
